Description

Description

Orinase Met (2/500mg) is a higher-strength dual-action tablet that combines Glimepiride and Metformin to offer more comprehensive blood sugar management for adults with type 2 diabetes mellitus. Each pack contains 30 tablets intended for oral use. This particular strength pairs a higher dose of Glimepiride (2mg) with the standard dose of Metformin (500mg), making it suitable for patients who need a more pronounced insulin-stimulating effect alongside Metformin’s established role in reducing liver glucose production and improving insulin sensitivity. Manufactured by CCL Pharmaceuticals, Orinase Met 2/500mg is typically prescribed for patients who have progressed beyond the lower-strength combination, or whose blood sugar levels call for a stronger initial approach to combination therapy, always under the supervision of a treating physician.

Ingredients

Each Orinase Met (2/500mg) tablet contains two active pharmaceutical ingredients: Glimepiride at a strength of 2mg, and Metformin Hydrochloride at a strength of 500mg. Glimepiride, from the sulfonylurea class, works by stimulating the pancreas to release more insulin, while Metformin, from the biguanide class, works primarily by reducing the amount of glucose produced by the liver and enhancing the body’s response to insulin. The tablet also includes standard pharmaceutical-grade excipients, such as fillers, binding agents, and disintegrants, along with a film coating that supports ease of swallowing. The full excipient composition can be found on the package insert or confirmed with a pharmacist, particularly for those with known sensitivities to specific ingredients.

Dosage Form

Orinase Met (2/500mg) is available as a film-coated oral tablet that combines both active ingredients into a single dosage unit. Each pack contains 30 tablets, providing a convenient one-month supply for patients on a once or twice daily dosing schedule, as determined by their doctor. Being a fixed-dose combination, it removes the need for taking two separate tablets, helping to simplify the daily treatment routine for patients managing a more advanced stage of diabetes care.

Uses

Orinase Met (2/500mg) is used to help manage blood sugar levels in adults with type 2 diabetes mellitus who require a stronger combined effect from both increased insulin release and reduced hepatic glucose production. It is often prescribed for patients who have not achieved adequate control on lower-strength combination therapy or Metformin alone, and who need a more assertive approach to bring their blood sugar closer to target levels. This strength may also be considered for patients with a more established diagnosis of type 2 diabetes who require ongoing, more intensive combination treatment. As with other Glimepiride and Metformin formulations, this medicine is not intended for use in type 1 diabetes or diabetic ketoacidosis.

How to Use

Orinase Met (2/500mg) should be taken strictly as prescribed by a doctor, who will determine the appropriate dosing schedule based on the patient’s blood sugar control, kidney function, and response to prior treatment. It is typically taken with meals, often once or twice daily, to help reduce the likelihood of gastrointestinal side effects associated with Metformin and to support more predictable absorption. The tablet should be swallowed whole with a glass of water, and meals should not be skipped after taking this medicine, as doing so can increase the risk of low blood sugar. Any further dose adjustments should only be made under medical guidance, and regular monitoring of blood sugar levels, along with periodic kidney function tests, is generally recommended throughout the course of treatment, particularly at this higher combination strength.

Side Effects

As a combination medicine at a higher Glimepiride strength, Orinase Met (2/500mg) may cause a range of side effects related to each individual component. Gastrointestinal symptoms such as nausea, diarrhea, stomach upset, or a metallic taste in the mouth are commonly associated with the Metformin component and often ease with continued use. Hypoglycemia, or low blood sugar, remains a notable concern linked to the higher Glimepiride dose, with symptoms including sweating, trembling, dizziness, confusion, or sudden hunger, requiring prompt attention with a fast-acting source of sugar. Some patients may also experience headache or general fatigue. In rare cases, Metformin has been associated with a serious condition called lactic acidosis, particularly in patients with impaired kidney or liver function, and immediate medical attention should be sought if symptoms such as unusual muscle pain, difficulty breathing, or pronounced weakness occur.

Pregnancy & Breastfeeding

Orinase Met (2/500mg) is generally not recommended for use during pregnancy, as blood sugar management in pregnant women with diabetes typically requires more precise, closely monitored control, often achieved through insulin therapy rather than oral combination medications. Women who are pregnant, planning to conceive, or who suspect they may be pregnant should inform their doctor promptly, as a different treatment approach is often considered safer under these circumstances. This medicine is also generally not advised during breastfeeding, as there is limited clarity on how the combined active ingredients may transfer into breast milk or affect a nursing infant. A healthcare provider should always be consulted before continuing or adjusting diabetes treatment during pregnancy or breastfeeding.

Storage Instructions

Orinase Met (2/500mg) tablets should be stored in a cool, dry place, away from direct sunlight and excessive humidity, ideally at normal room temperature. The tablets should remain in their original blister packaging until they are ready to be used, helping to preserve their stability and effectiveness. As with all medications, this product should be stored safely out of the reach and sight of children and pets. Tablets that have passed their expiry date should not be used, and any unused or expired medicine should be disposed of appropriately rather than discarded with regular household waste.

FAQs

Q: Why might a doctor prescribe the 2/500mg strength instead of 1/500mg?
A: This higher-strength combination is typically chosen when a patient’s blood sugar remains inadequately controlled on the lower-dose combination, requiring a stronger insulin-stimulating effect from the increased Glimepiride dose.

Q: Is this combination more likely to cause low blood sugar than the 1/500mg version?
A: Because it contains a higher dose of Glimepiride, the risk of hypoglycemia may be somewhat greater, making it important to take the medicine with meals and avoid skipping food afterward.

Q: Can this medicine be taken alongside insulin?
A: In some cases, doctors may combine this medicine with insulin for more comprehensive blood sugar control, but this should only be done under close medical supervision.

Q: What should I do if I miss a dose?
A: Take the missed dose as soon as you remember, unless it’s close to the time for your next dose, in which case skip it. Do not double the dose to make up for a missed one.

Q: Will I need more frequent monitoring at this strength?
A: Your doctor may recommend closer monitoring of blood sugar levels and kidney function, particularly during the initial period after starting or adjusting to this combination strength.

Disclaimer

Always use this medicine strictly according to your doctor’s instructions and prescribed dosage.